Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-22

Clinical Trial Update: Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A completed Phase 4 trial assessed the impact of atorvastatin on rheumatoid arthritis disease activity and HDL cholesterol function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED